Theravance Biopharma, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Theravance Biopharma, Inc. (TBPH) has a 3-month relative strength percentile of 66 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.2%, relative volume 2.79×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
66 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
TBPH is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $21M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $21M |
| VXFVanguard Extended Market ETF | 0.01% | $7M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TBPH Jan avg: -4.60% median: -1.99% win: 25% σ: 7.65% n: 4 2022-04-12 → 2026-05-29 | TBPH Feb avg: -1.04% median: -0.21% win: 0% σ: 1.74% n: 4 2022-04-12 → 2026-05-29 | TBPH Mar avg: -5.09% median: -4.89% win: 25% σ: 4.72% n: 4 2022-04-12 → 2026-05-29 | TBPH Apr avg: 1.48% median: 0.94% win: 60% σ: 5.55% n: 5 2022-04-12 → 2026-05-29 | TBPH May avg: -2.79% median: -4.06% win: 40% σ: 5.31% n: 5 2022-04-12 → 2026-05-29 | TBPH Jun avg: 3.64% median: 0.78% win: 50% σ: 12.00% n: 4 2022-04-12 → 2026-05-29 (current) | TBPH Jul avg: 3.24% median: -0.90% win: 50% σ: 10.91% n: 4 2022-04-12 → 2026-05-29 | TBPH Aug avg: 1.18% median: -0.62% win: 50% σ: 17.77% n: 4 2022-04-12 → 2026-05-29 | TBPH Sep avg: 1.52% median: 1.44% win: 50% σ: 9.45% n: 4 2022-04-12 → 2026-05-29 | TBPH Oct avg: 2.59% median: 1.32% win: 75% σ: 4.81% n: 4 2022-04-12 → 2026-05-29 | TBPH Nov avg: 17.42% median: 11.64% win: 100% σ: 14.15% n: 4 2022-04-12 → 2026-05-29 | TBPH Dec avg: 1.36% median: 3.00% win: 75% σ: 6.53% n: 4 2022-04-12 → 2026-05-29 |